These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35676794)

  • 41. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.
    Zaccardi F; Webb DR; Yates T; Davies MJ
    Postgrad Med J; 2016 Feb; 92(1084):63-9. PubMed ID: 26621825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adult-onset autoimmune diabetes.
    Buzzetti R; Maddaloni E; Gaglia J; Leslie RD; Wong FS; Boehm BO
    Nat Rev Dis Primers; 2022 Sep; 8(1):63. PubMed ID: 36138034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].
    Martinka E; Rončáková M; Mišániková M; Davani A
    Vnitr Lek; 2016; 62(7-8):521-33. PubMed ID: 27627073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Baseline Assessment of Circulating MicroRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin Secretion.
    Snowhite I; Pastori R; Sosenko J; Messinger Cayetano S; Pugliese A
    Diabetes; 2021 Feb; 70(2):638-651. PubMed ID: 33277338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology of insulin secretion.
    Scheen AJ
    Ann Endocrinol (Paris); 2004 Feb; 65(1):29-36. PubMed ID: 15122089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of pulsatile insulin secretion derived from peripheral plasma C-peptide concentrations by nonparametric stochastic deconvolution.
    Laurenti MC; Vella A; Varghese RT; Andrews JC; Sharma A; Kittah NE; Rizza RA; Matveyenko A; De Nicolao G; Cobelli C; Dalla Man C
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E687-E694. PubMed ID: 30807214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of endogenous residual insulin secretion by C-peptide measurement].
    Roehrich O; Judde De Larivière M; Gariani K
    Rev Med Suisse; 2024 May; 20(876):1069-1073. PubMed ID: 38812338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.
    Buzzetti R; Tuomi T; Mauricio D; Pietropaolo M; Zhou Z; Pozzilli P; Leslie RD
    Diabetes; 2020 Oct; 69(10):2037-2047. PubMed ID: 32847960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of hyperbaric oxygenation on residual insulin secretion in patients with diabetes mellitus type 1].
    Dedov II; Lukich VL; Bol'shakova TD; Gitel' EP; Dreval' AV
    Probl Endokrinol (Mosk); 1987; 33(4):10-5. PubMed ID: 3309933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis of feline diabetes mellitus.
    Lutz TA; Rand JS
    Vet Clin North Am Small Anim Pract; 1995 May; 25(3):527-52. PubMed ID: 7660530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults.
    Vauhkonen I; Niskanen L; Knip M; Ilonen J; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
    Diabetologia; 2000 Jan; 43(1):69-78. PubMed ID: 10663218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GAD treatment and insulin secretion in recent-onset type 1 diabetes.
    Ludvigsson J; Faresjö M; Hjorth M; Axelsson S; Chéramy M; Pihl M; Vaarala O; Forsander G; Ivarsson S; Johansson C; Lindh A; Nilsson NO; Aman J; Ortqvist E; Zerhouni P; Casas R
    N Engl J Med; 2008 Oct; 359(18):1909-20. PubMed ID: 18843118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
    van Raalte DH; Verchere CB
    Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.
    Hope SV; Knight BA; Shields BM; Hattersley AT; McDonald TJ; Jones AG
    Diabet Med; 2016 Nov; 33(11):1554-1558. PubMed ID: 27100275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fulminant type 1 diabetes as a model of nature to explore the role of C-peptide.
    Murase-Mishiba Y; Imagawa A; Hanafusa T
    Exp Diabetes Res; 2008; 2008():819123. PubMed ID: 18437231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Residual insulin secretion in insulin dependent diabetes mellitus.
    Rogers S; Silink M
    Arch Dis Child; 1985 Mar; 60(3):200-3. PubMed ID: 3885867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults.
    Vauhkonen I; Niskanen L; Knip M; Mykkänen LM; Haffner S; Uusitupa M; Laakso M
    Eur J Endocrinol; 2005 Aug; 153(2):265-73. PubMed ID: 16061833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-dependent diabetes mellitus: pathophysiology.
    Gerich JE
    Mayo Clin Proc; 1986 Oct; 61(10):787-91. PubMed ID: 3528691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of plasma C-peptide determination in the management of type II diabetes.
    Aro A
    Acta Endocrinol Suppl (Copenh); 1985; 272():79-82. PubMed ID: 3914808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.